American Journal of Epidemiology Advance Access originally published online on May 25, 2007
American Journal of Epidemiology 2007 166(4):393-402; doi:10.1093/aje/kwm096
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORIGINAL CONTRIBUTIONS |
Association between Glycosylated Hemoglobin Level and Cardiovascular and All-Cause Mortality in Type 1 Diabetes
1 Department of Community, Occupational, and Family Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
2 Department of Ophthalmology and Visual Sciences, School of Medicine and Public Health, University of Wisconsin, Madison, WI
Correspondence to Dr. Anoop Shankar, Department of Community, Occupational, and Family Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Block MD3, 16 Medical Drive, Singapore 117597 (e-mail: ashankar{at}nus.edu.sg).
Received for publication June 22, 2006. Accepted for publication February 22, 2007.
Hyperglycemia is implicated in the development and progression of microvascular complications in type 1 diabetes. In contrast, the association between hyperglycemia and macrovascular complications or mortality in type 1 diabetes is not clear. The authors studied a population-based cohort of 879 individuals with type 1 diabetes from Wisconsin, free of cardiovascular disease and end-stage renal disease at the baseline examination (1980–1982). The main outcome of interest was all-cause (n = 201) and cardiovascular (n = 132) mortality as of December 31, 2001. Elevated glycosylated hemoglobin levels were associated with all-cause and cardiovascular mortality, independent of duration of diabetes, smoking, hypertension, and proteinuria. The multivariable relative risks comparing the highest quartile of glycosylated hemoglobin (
12.1%) with the lowest quartile (
9.4%) were 2.42 (95% confidence interval: 1.54, 3.82; p-trend = 0.0006) for all-cause mortality and 3.28 (95% confidence interval: 1.77, 6.08; p-trend < 0.0001) for cardiovascular mortality. This association was present among both sexes and persisted in subgroup analyses by categories of diabetes duration, smoking, body mass index, proteinuria, and retinopathy. These data suggest that hyperglycemia is associated with all-cause and cardiovascular mortality among individuals with type 1 diabetes.
cardiovascular diseases; diabetes mellitus, type 1; glycosylation; hyperglycemia; mortality; Wisconsin
Abbreviations: CI, confidence interval; DCCT, Diabetes Control and Complications Trial; EDIC, Epidemiology of Diabetes Interventions and Complications; eGFR, estimated glomerular filtration rate; WESDR, Wisconsin Epidemiologic Study of Diabetic Retinopathy
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Conway, T. Costacou, and T. Orchard Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes? Diabetes and Vascular Disease Research, October 1, 2009; 6(4): 223 - 230. [Abstract] [PDF]
|
|
|
|
 |
|
 P.-H. Groop, M. C. Thomas, J. L. Moran, J. Waden, L. M. Thorn, V.-P. Makinen, M. Rosengard-Barlund, M. Saraheimo, K. Hietala, O. Heikkila, et al. The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes Diabetes, July 1, 2009; 58(7): 1651 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Brewer, C. S. Wright, N. Travier, C. W. Cunningham, J. Hornell, N. Pearce, and M. Jeffreys A New Zealand Linkage Study Examining the Associations Between A1C Concentration and Mortality Diabetes Care, June 1, 2008; 31(6): 1144 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Iqbal and A. H. Rubenstein Does Lowering of Blood Glucose Improve Cardiovascular Morbidity and Mortality? Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 163 - 167. [Full Text] [PDF]
|
|